WorthPointe LLC Takes $204,000 Position in Aflac Incorporated (NYSE:AFL)

WorthPointe LLC bought a new position in Aflac Incorporated (NYSE:AFL) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,822 shares of the financial services provider’s stock, valued at approximately $204,000.

A number of other institutional investors have also recently bought and sold shares of the business. Y.D. More Investments Ltd acquired a new position in shares of Aflac in the 2nd quarter worth approximately $25,000. Darwin Wealth Management LLC bought a new position in shares of Aflac in the third quarter valued at approximately $34,000. Covestor Ltd grew its position in Aflac by 41.8% during the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after acquiring an additional 107 shares during the last quarter. Kennebec Savings Bank acquired a new stake in Aflac during the 3rd quarter valued at $45,000. Finally, Catalyst Capital Advisors LLC bought a new position in Aflac in the 3rd quarter valued at $51,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Stock Up 0.7 %

Aflac stock opened at $114.01 on Wednesday. Aflac Incorporated has a fifty-two week low of $75.07 and a fifty-two week high of $115.50. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. The firm has a market capitalization of $63.34 billion, a price-to-earnings ratio of 17.17, a PEG ratio of 2.18 and a beta of 0.96. The company’s 50 day simple moving average is $110.88 and its 200 day simple moving average is $101.05.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.47. The company had revenue of $2.95 billion during the quarter, compared to analyst estimates of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The firm’s revenue was down 40.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.84 EPS. As a group, sell-side analysts anticipate that Aflac Incorporated will post 7.22 EPS for the current year.

Aflac Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac’s dividend payout ratio is currently 30.12%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Truist Financial increased their target price on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, November 1st. Evercore ISI raised their price objective on shares of Aflac from $84.00 to $90.00 and gave the company an “underperform” rating in a research report on Thursday, September 26th. TD Cowen initiated coverage on shares of Aflac in a research report on Wednesday, October 9th. They set a “hold” rating and a $102.00 target price on the stock. Morgan Stanley lifted their target price on Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research note on Monday, August 19th. Finally, Barclays initiated coverage on Aflac in a research note on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price target on the stock. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $97.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.